| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.025 | 0.4 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.4 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |